Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Status: Enrolling
Updated:  4/12/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Status: Enrolling
Updated: 4/12/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Status: Enrolling
Updated:  4/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Status: Enrolling
Updated: 4/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Tucson, AZ
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Aurora, CO
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Atlanta, GA
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Chicago, IL
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
St Louis, MO
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Omaha, NE
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Lebanon, NH
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Portland, OR
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Greenville, SC
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Dallas, TX
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Madison, WI
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  4/12/2016
mi
from
Hamilton,
Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 4/12/2016
mi
from
Hamilton,
Click here to add this to my saved trials
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated:  4/13/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated: 4/13/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated:  4/13/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Phase I Study of Belinostat (PXD-101) and Velcade (Bortezomib) in Relapsed or Refractory Acute Leukemia/ Myelodysplastic Syndrome
Status: Enrolling
Updated: 4/13/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Diindolylmethane in Treating Patients With Breast Cancer
Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study
Status: Enrolling
Updated:  4/13/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Diindolylmethane in Treating Patients With Breast Cancer
Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study
Status: Enrolling
Updated: 4/13/2016
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Bronx/Lebanon Hospital
mi
from
Bronx, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Bronx/Lebanon Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Jacobi Medical Center
mi
from
Bronx, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Montefiore Medical Center
mi
from
Bronx, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Brooklyn Hospital Center
mi
from
Brooklyn, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Brooklyn Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Kings County Hospital
mi
from
Brooklyn, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Kings County Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Lutheran Medical Center
mi
from
Brooklyn, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Lutheran Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
University Hospital of Brooklyn at Long Island College Hospital
mi
from
Brooklyn, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
University Hospital of Brooklyn at Long Island College Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Queens Hospital Center
mi
from
Jamaica, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Queens Hospital Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated:  4/13/2016
Metropolitan Hosp Ctr
mi
from
New York, NY
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
Implementing a Tracking & Feedback Registry to Allay Cancer Therapy Disparities
Status: Enrolling
Updated: 4/13/2016
Metropolitan Hosp Ctr
mi
from
New York, NY
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site #10
mi
from
Goodyear, AZ
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site #10
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #42
mi
from
Greenbrae, CA
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #42
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #39
mi
from
Denver, CO
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #39
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #34
mi
from
Detroit, MI
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #34
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #34
mi
from
St. Louis, MO
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #34
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #36
mi
from
Las Vegas, NV
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #36
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: # 37
mi
from
Oklahoma City, OK
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: # 37
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: # 33
mi
from
San Antonio, TX
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: # 33
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #74
mi
from
Arkhangelsk,
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #74
mi
from
Arkhangelsk,
Click here to add this to my saved trials
Activity & Cognition After Treatment for Breast Cancer
Activity & Cognition After Treatment (ACT) for Breast Cancer
Status: Enrolling
Updated:  4/13/2016
Freer Hall, University of Illinois
mi
from
Urbana, IL
Activity & Cognition After Treatment for Breast Cancer
Activity & Cognition After Treatment (ACT) for Breast Cancer
Status: Enrolling
Updated: 4/13/2016
Freer Hall, University of Illinois
mi
from
Urbana, IL
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Children's Hospital Central California
mi
from
Madera, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Children's Hospital Central California
mi
from
Madera, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Lucile Packard Children's Hospital Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated:  4/14/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Treatment of High Risk Renal Tumors: A Groupwide Phase II Study
Status: Enrolling
Updated: 4/14/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials